2026年全球免疫腫瘤診斷市場報告

近年來，腫瘤免疫診斷市場發展迅速。預計該市場將從2025年的138億美元成長到2026年的151.5億美元，複合年成長率（CAGR）為9.7%。這一成長主要歸功於全球癌症發病率的上升、靶向癌症療法的日益普及、醫院診斷檢查室的擴張、免疫組織化學在腫瘤學領域的應用日益廣泛以及生物標記發現技術的進步。

預計未來幾年，腫瘤免疫診斷市場將維持強勁成長，年複合成長率（CAGR）將達到10.0%，2030年市場規模將達到221.6億美元。預測期內的成長要素包括：對個人化癌症免疫療法的需求不斷成長、液態生物檢體和非侵入性診斷技術的擴展、人工智慧驅動的診斷平台應用日益廣泛、精準醫療和伴隨診斷的發展，以及對腫瘤學研究和臨床試驗投入的增加。預測期內的關鍵趨勢包括：基於液態生物檢體活體組織切片的腫瘤免疫診斷檢測方法，用於早期癌症檢測和監測；用於表徵腫瘤微環境的多階段免疫分析平台；用於個性化癌症免疫療法選擇的伴隨診斷試劑盒；用於癌症分層的基於高靈敏度流式細胞技術的免疫細胞化學方法；以及用於解讀腫瘤免疫標記的人工智慧驅動的人工智慧驅動的人工智慧驅動的數字病理軟體。

全球癌症負擔日益加重預計將推動免疫腫瘤診斷市場在預測期內成長。癌症是一種異常細胞不受控制地增殖和發展的疾病，癌細胞可能侵入鄰近組織或轉移到身體其他部位，並影響正常的生理功能。隨著年齡的成長，基因突變和細胞損傷的累積會增加腫瘤形成的可能性，導致癌症發生率上升。免疫腫瘤診斷透過支持生物標記的檢測、免疫系統分析和精準腫瘤檢測，促進癌症治療。這些是開發個人化標靶癌症療法、提高治療效果、改善患者預後以及輔助臨床決策的關鍵要素。例如，截至2024年2月，總部位於瑞士的政府間組織世界衛生組織（世衛組織）預測，2050年，全球新患者將超過3,500萬例，比2022年估計的2,000萬例增加77%。因此，全球癌症發生率的上升正在推動免疫腫瘤診斷市場的成長。

免疫腫瘤診斷市場的領導者正致力於開發創新解決方案，例如人工智慧驅動的多模態免疫分析檢測，以提高癌症診斷的精準度，增強治療反應預測，並支持個人化免疫療法決策。人工智慧驅動的多模態免疫分析檢測是一種先進的診斷解決方案，它利用人工智慧分析多種生物數據類型，包括基因組學、蛋白質組學和免疫生物標記，從而評估免疫系統的反應並指導個人化癌症治療決策。例如，2024年11月，總部位於美國的人工智慧和精準醫療公司Tempus AI推出了免疫譜評分（IPS）演算法檢測，這是一種人工智慧驅動的多模態免疫分析檢測。它旨在改進免疫反應模式的評估，並為癌症患者的免疫腫瘤治療決策提供更充分的資訊支持。 IPS檢測是一種多模態生物標記檢測，它整合了DNA和RNA定序結果以及臨床和分子數據，產生0到100的預測性免疫反應評分。

目錄

第1章執行摘要

第2章 市場特徵

• 市場定義和範圍
• 市場區隔
• 主要產品和服務概述
• 全球免疫腫瘤診斷市場：吸引力評分及分析
• 成長潛力分析、競爭評估、策略適宜性評估、風險狀況評估

第3章 市場供應鏈分析

• 供應鏈與生態系概述
• 清單：主要原料、資源和供應商
• 主要經銷商和通路合作夥伴名單
• 主要最終用戶列表

第4章：全球市場趨勢與策略

• 關鍵科技與未來趨勢
  • 生物技術、基因組學和精準醫療
  • 人工智慧和自主智慧
  • 數位化、雲端運算、巨量資料、網路安全
  • 工業4.0和智慧製造
  • 物聯網、智慧基礎設施、互聯生態系統
• 主要趨勢
  • 一種基於液態生物檢體的免疫腫瘤診斷檢測方法，用於癌症的早期檢測和後續觀察。
  • 用於表徵腫瘤微環境的多重免疫分析平台
  • 用於選擇個人化癌症免疫療法的伴隨診斷試劑盒
  • 基於高靈敏度流式細胞技術的免疫細胞分析在癌症分層的應用
  • 用於免疫腫瘤學生物標記分析的人工智慧驅動數位病理軟體

第5章 終端用戶產業市場分析

• 醫院
• 診斷檢查室
• 學術研究機構
• 製藥和生物技術公司
• 其他最終用戶

第6章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅的影響、關稅戰和貿易保護主義對供應鏈的影響，以及 COVID-19 疫情對市場的影響。

第7章：全球策略分析架構、目前市場規模、市場對比及成長率分析

• 全球免疫腫瘤診斷市場：PESTEL 分析
• 全球免疫腫瘤診斷市場：規模、對比及成長率分析
• 全球免疫腫瘤診斷市場表現：規模與成長，2020-2025年
• 全球免疫腫瘤診斷市場預測：規模與成長，2025-2030年，2035年

第8章：全球市場總規模（TAM）

第9章 市場細分

• 依產品類型
• 檢測方法、試劑盒、試劑、儀器、軟體
• 透過技術
• 聚合酵素鏈鎖反應（PCR）、次世代定序、免疫組織化學、流式細胞技術和其他技術
• 透過使用
• 癌症診斷、研究與開發、藥物開發及其他應用
• 最終用戶
• 醫院、診斷檢測實驗室、學術和研究機構、製藥和生物技術公司
• 按類型細分：偵測
• 蛋白質生物標記檢測、基因生物標記檢測、多重免疫檢測、伴隨診斷檢測、腫瘤突變檢測、免疫分析檢測、循環性腫瘤細胞檢測、液態生物檢體檢測、基於細胞的功能檢測、太空生物學檢測
• 按類型細分：套件
• 樣本製備試劑盒、核酸萃取試劑盒、生物標記檢測試劑盒、免疫組織化學試劑盒、流式細胞技術盒、聚合酵素鏈鎖反應(PCR) 試劑盒、定序樣品製備盒、腫瘤分析試劑盒、伴隨診斷試劑盒、細胞分離試劑盒
• 按類型細分：試劑
• 抗體試劑、染色試劑、檢測試劑、緩衝試劑、螢光標記試劑、酵素基材試劑、細胞培養試劑、分子探針試劑、對照增強試劑、封閉試劑
• 按類型細分：設備
• 流式細胞技術儀、數位病理診斷設備、定序設備、聚合酵素鏈鎖反應（PCR）設備、顯微鏡設備、免疫檢測分析儀、玻片掃描儀、細胞影像設備、自動化樣品製備設備、生物標記分析儀
• 按類型細分：軟體
• 生物資訊軟體、臨床決策支援軟體、影像分析軟體、資料管理軟體、定序分析軟體、實驗室資訊管理軟體、數位病理學軟體、生物標記解讀軟體、人工智慧診斷軟體、雲端分析軟體

第10章 區域與國別分析

第11章 亞太市場

第12章：中國市場

第13章：印度市場

第14章：日本市場

第15章：澳洲市場

第16章：印尼市場

第17章：韓國市場

第18章 台灣市場

第19章 東南亞市場

第20章 西歐市場

第21章英國市場

第22章：德國市場

第23章：法國市場

第24章：義大利市場

第25章：西班牙市場

第26章：東歐市場

第27章：俄羅斯市場

第28章 北美市場

第29章：美國市場

第30章：加拿大市場

第31章：南美市場

第32章：巴西市場

第33章 中東市場

第34章：非洲市場

第35章 市場監理與投資環境

第36章：競爭格局與公司概況

• 免疫腫瘤診斷市場：競爭格局及市場佔有率（2024年）
• 免疫腫瘤診斷市場：公司評估矩陣
• 免疫腫瘤診斷市場：公司概況
  • Roche Diagnostics International AG
  • Thermo Fisher Scientific Inc.
  • Abbott Laboratories
  • Siemens Healthineers AG
  • Merck KGaA

第37章 其他大型企業和創新企業

• Agilent Technologies Inc., Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN NV, Bio-Techne Corporation, Natera Inc., Caris Life Sciences Inc., Myriad Genetics Inc., NeoGenomics Inc., Guardant Health Inc., Promega Corporation, Takara Bio Inc., Bioneer Corporation, Vazyme Biotech Co. Ltd., Exact Sciences Corporation

第38章：全球市場競爭基準分析與儀錶板

第39章：預計進入市場的新創企業

第40章 重大併購

第41章 具有高市場潛力的國家、細分市場與策略

• 2030年免疫腫瘤診斷市場：提供新機會的國家
• 2030年免疫腫瘤診斷市場：蘊藏新機會的細分領域
• 2030年免疫腫瘤診斷市場：成長策略
  • 基於市場趨勢的策略
  • 競爭對手的策略

第42章附錄

Immuno-oncology diagnosis involves the identification and evaluation of cancer-associated biomarkers and immune system responses to better understand the interaction between tumors and the immune system. It assists in determining cancer characteristics, supports precise diagnosis, and helps guide treatment planning. Immuno-oncology diagnostics facilitate patient stratification, improve therapy selection, and enable monitoring of treatment response, contributing to better overall cancer care outcomes.

The primary product types of immuno-oncology diagnosis include assays, kits, reagents, instruments, and software. Assays are diagnostic tests designed to identify, quantify, and evaluate biological markers associated with immune responses and cancer-related conditions. These products employ technologies including polymerase chain reaction, next-generation sequencing, immunohistochemistry, flow cytometry, and other advanced technologies. They are used in cancer diagnosis, research, drug development, and other applications, serving hospitals, diagnostic laboratories, academic and research institutes, and pharmaceutical and biotechnology companies.

Tariffs are influencing the immuno oncology diagnosis market by increasing the cost of imported diagnostic reagents, sequencing platforms, and advanced biomarker detection kits required for cancer diagnostics and research activities. This is creating cost pressures across high-value segments such as next-generation sequencing, flow cytometry, and immunohistochemistry technologies, with hospitals, diagnostic laboratories, and biotechnology companies encountering higher procurement expenses. Import-dependent regions, particularly across Asia-Pacific and parts of Europe, are also experiencing delays in accessing advanced diagnostic technologies alongside supply chain disruptions. At the same time, tariffs are encouraging domestic production of diagnostic kits, regional manufacturing of reagents, and strategic technology transfer partnerships, strengthening long-term resilience and innovation within cancer diagnostics ecosystems.

The immuno oncology diagnosis market research report is one of a series of new reports from The Business Research Company that provides immuno oncology diagnosis market statistics, including immuno oncology diagnosis industry global market size, regional shares, competitors with a immuno oncology diagnosis market share, detailed immuno oncology diagnosis market segments, market trends and opportunities, and any further data you may need to thrive in the immuno oncology diagnosis industry. This immuno oncology diagnosis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The immuno oncology diagnosis market size has grown strongly in recent years. It will grow from $13.8 billion in 2025 to $15.15 billion in 2026 at a compound annual growth rate (CAGR) of 9.7%. The growth in the historic period can be attributed to rising global cancer incidence rates, increasing adoption of targeted cancer therapies, expansion of hospital based diagnostic laboratories, growing use of immunohistochemistry techniques in oncology, improvements in biomarker discovery technologies.

The immuno oncology diagnosis market size is expected to see strong growth in the next few years. It will grow to $22.16 billion in 2030 at a compound annual growth rate (CAGR) of 10.0%. The growth in the forecast period can be attributed to increasing demand for personalized cancer immunotherapy, expansion of liquid biopsy and non invasive diagnostics, rising adoption of ai driven diagnostic platforms, growth in precision medicine and companion diagnostics, increasing investment in oncology research and clinical trials. Major trends in the forecast period include liquid biopsy based immuno-oncology diagnostic assays for early cancer detection and monitoring, multiplex immune profiling platforms for tumor microenvironment characterization, companion diagnostic kits for personalized cancer immunotherapy selection, high sensitivity flow cytometry based immune cell analysis for cancer stratification, ai enabled digital pathology software for immuno-oncology biomarker interpretation.

The rising global burden of cancer is anticipated to drive the growth of the immuno-oncology diagnosis market in the forecast period. Cancer is a medical condition involving the uncontrolled multiplication and progression of abnormal cells, which can infiltrate nearby tissues and metastasize to other areas of the body, affecting normal physiological functions. The incidence of cancer is increasing due to the growing elderly population, as aging contributes to the accumulation of genetic alterations and cellular damage, thereby increasing the likelihood of tumor formation. Immuno-oncology diagnosis facilitates cancer care by supporting biomarker detection, immune system profiling, and precision oncology testing, which are essential for developing personalized and targeted cancer treatment approaches, improving therapeutic effectiveness, patient outcomes, and clinical decision-making. For instance, in February 2024, according to the World Health Organization, a Switzerland-based intergovernmental organization, global cancer cases were projected to exceed 35 million new cases by 2050, representing a 77% rise compared with the estimated 20 million cases recorded in 2022. Therefore, the increasing global prevalence of cancer is driving the growth of the immuno-oncology diagnosis market.

Key companies operating in the immuno-oncology diagnosis market are focusing on developing innovative solutions, such as AI-enabled multimodal immune profiling tests, to enhance precision cancer diagnosis, improve treatment response prediction, and support personalized immunotherapy decision-making. AI-enabled multimodal immune profiling tests are advanced diagnostic solutions that use artificial intelligence to analyze multiple biological data types, including genomic, proteomic, and immune biomarkers, to evaluate immune system responses and guide personalized cancer treatment decisions. For example, in November 2024, Tempus AI, Inc., a US-based artificial intelligence and precision medicine company, launched the Immune Profile Score (IPS) algorithmic test, an AI-enabled multimodal immune profiling test. It is designed to improve the evaluation of immune response patterns and support more informed immuno-oncology treatment decisions for cancer patients. The IPS test is a multimodal biomarker assay that integrates DNA and RNA sequencing insights with clinical and molecular data to generate a predictive immune response score ranging from 0 to 100.

In July 2025, Alden Scientific, a US-based research institute and health technology company, acquired Oncimmune Germany GmbH for an undisclosed amount. With this acquisition, Alden Scientific intended to reinforce its global position in precision medicine by expanding its expertise in immune profiling, autoantibody biomarker discovery, and multi-omics analytics, while obtaining access to Oncimmune's ImmunoINSIGHTS platform and its extensive antigen library containing more than 9,000 human and multi-species antigens. Oncimmune Germany GmbH is a Germany-based company providing immuno-oncology diagnostics, with expertise in biomarker discovery, immune profiling, and immunodiagnostic services.

Major companies operating in the immuno oncology diagnosis market report are Roche Diagnostics International AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers AG, Merck KGaA, Agilent Technologies Inc., Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Bio-Techne Corporation, Natera Inc., Caris Life Sciences Inc., Myriad Genetics Inc., NeoGenomics Inc., Guardant Health Inc., Promega Corporation, Takara Bio Inc., Bioneer Corporation, Vazyme Biotech Co. Ltd., Exact Sciences Corporation, Hologic Inc., Becton Dickinson and Company

North America was the dominating region in the immuno oncology diagnosis market in 2025. Asia-Pacific is expected to be the rapidly growing region in the forecast period. The regions covered in the immuno oncology diagnosis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the immuno oncology diagnosis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The immuno-oncology diagnosis market consists of revenues earned by entities by providing services such as biomarker testing, molecular diagnostics, immunohistochemistry, flow cytometry, next-generation sequencing, companion diagnostics, and tumor profiling solutions. The market value includes the value of related goods sold by the service provider or included within the service offering. The immuno-oncology diagnosis market also includes sales of biomarker panels, companion diagnostics, molecular profiling tools, and digital pathology systems. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Immuno Oncology Diagnosis Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses immuno oncology diagnosis market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for immuno oncology diagnosis ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The immuno oncology diagnosis market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Product Type: Assays; Kits; Reagents; Instruments; Software
• 2) By Technology: Polymerase Chain Reaction; Next Generation Sequencing; Immunohistochemistry; Flow Cytometry; Other Technologies
• 3) By Application: Cancer Diagnosis; Research; Drug Development; Other Applications
• 4) By End User: Hospitals; Diagnostic Laboratories; Academic And Research Institutes; Pharmaceutical And Biotechnology Companies
• Subsegments:
• 1) By Assays: Protein Biomarker Assays; Genomic Biomarker Assays; Multiplex Immunoassays; Companion Diagnostic Assays; Tumor Mutation Detection Assays; Immune Profiling Assays; Circulating Tumor Cell Assays; Liquid Biopsy Assays; Cell Based Functional Assays; Spatial Biology Assays
• 2) By Kits: Sample Preparation Kits; Nucleic Acid Extraction Kits; Biomarker Detection Kits; Immunohistochemistry Kits; Flow Cytometry Kits; Polymerase Chain Reaction Kits; Sequencing Library Preparation Kits; Tumor Profiling Kits; Companion Diagnostic Kits; Cell Isolation Kits
• 3) By Reagents: Antibodies Reagents; Staining Reagents; Detection Reagents; Buffer Reagents; Fluorescent Labeling Reagents; Enzyme Substrate Reagents; Cell Culture Reagents; Molecular Probe Reagents; Contrast Enhancement Reagents; Blocking Reagents
• 4) By Instruments: Flow Cytometry Instruments; Digital Pathology Instruments; Sequencing Instruments; Polymerase Chain Reaction Instruments; Microscopy Instruments; Immunoassay Analyzers; Slide Scanning Instruments; Cell Imaging Instruments; Automated Sample Preparation Instruments; Biomarker Analysis Instruments
• 5) By Software: Bioinformatics Software; Clinical Decision Support Software; Image Analysis Software; Data Management Software; Sequencing Analysis Software; Laboratory Information Management Software; Digital Pathology Software; Biomarker Interpretation Software; Artificial Intelligence Diagnostic Software; Cloud Based Analytics Software
• Companies Mentioned: Roche Diagnostics International AG; Thermo Fisher Scientific Inc.; Abbott Laboratories; Siemens Healthineers AG; Merck KGaA; Agilent Technologies Inc.; Illumina Inc.; Bio-Rad Laboratories Inc.; QIAGEN N.V.; Bio-Techne Corporation; Natera Inc.; Caris Life Sciences Inc.; Myriad Genetics Inc.; NeoGenomics Inc.; Guardant Health Inc.; Promega Corporation; Takara Bio Inc.; Bioneer Corporation; Vazyme Biotech Co. Ltd.; Exact Sciences Corporation; Hologic Inc.; Becton Dickinson and Company
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Immuno Oncology Diagnosis Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Immuno Oncology Diagnosis Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Immuno Oncology Diagnosis Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Immuno Oncology Diagnosis Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Biotechnology, Genomics & Precision Medicine
  • 4.1.2 Artificial Intelligence & Autonomous Intelligence
  • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.4 Industry 4.0 & Intelligent Manufacturing
  • 4.1.5 Internet of Things (IoT), Smart Infrastructure & Connected Ecosystems
• 4.2. Major Trends
  • 4.2.1 Liquid Biopsy Based Immuno Oncology Diagnostic Assays For Early Cancer Detection And Monitoring
  • 4.2.2 Multiplex Immune Profiling Platforms For Tumor Microenvironment Characterization
  • 4.2.3 Companion Diagnostic Kits For Personalized Cancer Immunotherapy Selection
  • 4.2.4 High Sensitivity Flow Cytometry Based Immune Cell Analysis For Cancer Stratification
  • 4.2.5 AI Enabled Digital Pathology Software For Immuno Oncology Biomarker Interpretation

5. Immuno Oncology Diagnosis Market Analysis Of End Use Industries

• 5.1 Hospitals
• 5.2 Diagnostic Laboratories
• 5.3 Academic And Research Institutes
• 5.4 Pharmaceutical And Biotechnology Companies
• 5.5 Other End Users

6. Immuno Oncology Diagnosis Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Immuno Oncology Diagnosis Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Immuno Oncology Diagnosis PESTEL Analysis (Political, Economical, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Immuno Oncology Diagnosis Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Immuno Oncology Diagnosis Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Immuno Oncology Diagnosis Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Immuno Oncology Diagnosis Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Immuno Oncology Diagnosis Market Segmentation

• 9.1. Global Immuno Oncology Diagnosis Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Assays, Kits, Reagents, Instruments, Software
• 9.2. Global Immuno Oncology Diagnosis Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Polymerase Chain Reaction, Next Generation Sequencing, Immunohistochemistry, Flow Cytometry, Other Technologies
• 9.3. Global Immuno Oncology Diagnosis Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Cancer Diagnosis, Research, Drug Development, Other Applications
• 9.4. Global Immuno Oncology Diagnosis Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Hospitals, Diagnostic Laboratories, Academic And Research Institutes, Pharmaceutical And Biotechnology Companies
• 9.5. Global Immuno Oncology Diagnosis Market, Sub-Segmentation Of Assays, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Protein Biomarker Assays, Genomic Biomarker Assays, Multiplex Immunoassays, Companion Diagnostic Assays, Tumor Mutation Detection Assays, Immune Profiling Assays, Circulating Tumor Cell Assays, Liquid Biopsy Assays, Cell Based Functional Assays, Spatial Biology Assays
• 9.6. Global Immuno Oncology Diagnosis Market, Sub-Segmentation Of Kits, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Sample Preparation Kits, Nucleic Acid Extraction Kits, Biomarker Detection Kits, Immunohistochemistry Kits, Flow Cytometry Kits, Polymerase Chain Reaction Kits, Sequencing Library Preparation Kits, Tumor Profiling Kits, Companion Diagnostic Kits, Cell Isolation Kits
• 9.7. Global Immuno Oncology Diagnosis Market, Sub-Segmentation Of Reagents, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Antibodies Reagents, Staining Reagents, Detection Reagents, Buffer Reagents, Fluorescent Labeling Reagents, Enzyme Substrate Reagents, Cell Culture Reagents, Molecular Probe Reagents, Contrast Enhancement Reagents, Blocking Reagents
• 9.8. Global Immuno Oncology Diagnosis Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Flow Cytometry Instruments, Digital Pathology Instruments, Sequencing Instruments, Polymerase Chain Reaction Instruments, Microscopy Instruments, Immunoassay Analyzers, Slide Scanning Instruments, Cell Imaging Instruments, Automated Sample Preparation Instruments, Biomarker Analysis Instruments
• 9.9. Global Immuno Oncology Diagnosis Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Bioinformatics Software, Clinical Decision Support Software, Image Analysis Software, Data Management Software, Sequencing Analysis Software, Laboratory Information Management Software, Digital Pathology Software, Biomarker Interpretation Software, Artificial Intelligence Diagnostic Software, Cloud Based Analytics Software

10. Immuno Oncology Diagnosis Market Regional And Country Analysis

• 10.1. Global Immuno Oncology Diagnosis Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Immuno Oncology Diagnosis Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Immuno Oncology Diagnosis Market

• 11.1. Asia-Pacific Immuno Oncology Diagnosis Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Immuno Oncology Diagnosis Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Immuno Oncology Diagnosis Market

• 12.1. China Immuno Oncology Diagnosis Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Immuno Oncology Diagnosis Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Immuno Oncology Diagnosis Market

• 13.1. India Immuno Oncology Diagnosis Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Immuno Oncology Diagnosis Market

• 14.1. Japan Immuno Oncology Diagnosis Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Immuno Oncology Diagnosis Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Immuno Oncology Diagnosis Market

• 15.1. Australia Immuno Oncology Diagnosis Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Immuno Oncology Diagnosis Market

• 16.1. Indonesia Immuno Oncology Diagnosis Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Immuno Oncology Diagnosis Market

• 17.1. South Korea Immuno Oncology Diagnosis Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea Immuno Oncology Diagnosis Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Immuno Oncology Diagnosis Market

• 18.1. Taiwan Immuno Oncology Diagnosis Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan Immuno Oncology Diagnosis Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Immuno Oncology Diagnosis Market

• 19.1. South East Asia Immuno Oncology Diagnosis Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia Immuno Oncology Diagnosis Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Immuno Oncology Diagnosis Market

• 20.1. Western Europe Immuno Oncology Diagnosis Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe Immuno Oncology Diagnosis Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Immuno Oncology Diagnosis Market

• 21.1. UK Immuno Oncology Diagnosis Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Immuno Oncology Diagnosis Market

• 22.1. Germany Immuno Oncology Diagnosis Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Immuno Oncology Diagnosis Market

• 23.1. France Immuno Oncology Diagnosis Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Immuno Oncology Diagnosis Market

• 24.1. Italy Immuno Oncology Diagnosis Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Immuno Oncology Diagnosis Market

• 25.1. Spain Immuno Oncology Diagnosis Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Immuno Oncology Diagnosis Market

• 26.1. Eastern Europe Immuno Oncology Diagnosis Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe Immuno Oncology Diagnosis Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Immuno Oncology Diagnosis Market

• 27.1. Russia Immuno Oncology Diagnosis Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Immuno Oncology Diagnosis Market

• 28.1. North America Immuno Oncology Diagnosis Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America Immuno Oncology Diagnosis Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Immuno Oncology Diagnosis Market

• 29.1. USA Immuno Oncology Diagnosis Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA Immuno Oncology Diagnosis Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Immuno Oncology Diagnosis Market

• 30.1. Canada Immuno Oncology Diagnosis Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada Immuno Oncology Diagnosis Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Immuno Oncology Diagnosis Market

• 31.1. South America Immuno Oncology Diagnosis Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America Immuno Oncology Diagnosis Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Immuno Oncology Diagnosis Market

• 32.1. Brazil Immuno Oncology Diagnosis Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Immuno Oncology Diagnosis Market

• 33.1. Middle East Immuno Oncology Diagnosis Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East Immuno Oncology Diagnosis Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Immuno Oncology Diagnosis Market

• 34.1. Africa Immuno Oncology Diagnosis Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa Immuno Oncology Diagnosis Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Immuno Oncology Diagnosis Market Regulatory and Investment Landscape

36. Immuno Oncology Diagnosis Market Competitive Landscape And Company Profiles

• 36.1. Immuno Oncology Diagnosis Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. Immuno Oncology Diagnosis Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. Immuno Oncology Diagnosis Market Company Profiles
  • 36.3.1. Roche Diagnostics International AG Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis

37. Immuno Oncology Diagnosis Market Other Major And Innovative Companies

• Agilent Technologies Inc., Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Bio-Techne Corporation, Natera Inc., Caris Life Sciences Inc., Myriad Genetics Inc., NeoGenomics Inc., Guardant Health Inc., Promega Corporation, Takara Bio Inc., Bioneer Corporation, Vazyme Biotech Co. Ltd., Exact Sciences Corporation

38. Global Immuno Oncology Diagnosis Market Competitive Benchmarking And Dashboard

39. Upcoming Startups in the Market

40. Key Mergers And Acquisitions In The Immuno Oncology Diagnosis Market

41. Immuno Oncology Diagnosis Market High Potential Countries, Segments and Strategies

• 41.1 Immuno Oncology Diagnosis Market In 2030 - Countries Offering Most New Opportunities
• 41.2 Immuno Oncology Diagnosis Market In 2030 - Segments Offering Most New Opportunities
• 41.3 Immuno Oncology Diagnosis Market In 2030 - Growth Strategies
  • 41.3.1 Market Trend Based Strategies
  • 41.3.2 Competitor Strategies

42. Appendix

• 42.1. Abbreviations
• 42.2. Currencies
• 42.3. Historic And Forecast Inflation Rates
• 42.4. Research Inquiries
• 42.5. The Business Research Company
• 42.6. Copyright And Disclaimer